menu
    • menu

    Company profile for Alladapt Immunotherapeutics

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are dedicated to developing and commercializing effective and broadly applicable interventions for food allergy. Food allergy is a disease of the immune system that is triggered by an exceptionally broad range of commonly allergenic foods such as cow’s milk, eggs, tree nuts, peanuts, shellfish and even sesame. In a perfect world, the human immune system would adapt to all foods. However, in tens of millions of people, th...
    We are dedicated to developing and commercializing effective and broadly applicable interventions for food allergy. Food allergy is a disease of the immune system that is triggered by an exceptionally broad range of commonly allergenic foods such as cow’s milk, eggs, tree nuts, peanuts, shellfish and even sesame. In a perfect world, the human immune system would adapt to all foods. However, in tens of millions of people, the immune system wrongly recognizes some food proteins as harmful and does not adapt. We envision a world where, with help from oral immunotherapy, the immune system can adapt to nearly all food allergens.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alladapt ImmunotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Alladapt Immunotherapeutics, Inc. 611 Santa Cruz Avenue Menlo Park, CA
    Telephone
    Telephone
    650-420-3900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alladapt.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alladapt/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101
    Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101

    22 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/22/2784744/0/en/Alladapt-Immunotherapeutics-Receives-FDA-Fast-Track-Designation-for-ADP101-for-the-Treatment-of-Mono-and-Multi-Food-Allergies.html

    GLOBENEWSWIRE
    22 Nov 2023
    Share Share
    Alladapt Immunotherapeutics Presents Phase 1/2 Harmony Data of ADP101
    Alladapt Immunotherapeutics Presents Phase 1/2 Harmony Data of ADP101

    09 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/09/2777583/0/en/Alladapt-Immunotherapeutics-Presents-Phase-1-2-Harmony-Data-Demonstrating-Therapeutic-Potential-and-Safety-of-ADP101-for-the-Treatment-of-Food-Allergy-at-2023-ACAAI-Annual-Meeting.html

    GLOBENEWSWIRE
    09 Nov 2023
    Share Share
    Alladapt Announces Data from Phase 1/2 Harmony Study Evaluating ADP101
    Alladapt Announces Data from Phase 1/2 Harmony Study Evaluating ADP101

    13 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/13/2686998/0/en/Alladapt-Immunotherapeutics-Announces-Topline-Pediatric-Data-from-Phase-1-2-Harmony-Study-Evaluating-ADP101-for-the-Treatment-of-Patients-with-Mono-and-Multi-Food-Allergy-as-Presen.html

    GLOBENEWSWIRE
    13 Jun 2023
    Share Share
    Alladapt touts data on food allergy drug as it preps for PhIII
    Alladapt touts data on food allergy drug as it preps for PhIII

    13 Jun 2023

    // Lei Lei Wu ENDPTS

    https://endpts.com/alladapt-touts-data-on-food-allergy-drug-as-it-preps-for-phiii/

    Lei Lei Wu ENDPTS
    13 Jun 2023
    Share Share
    Alladapt Announces Presentations at European Academy of (EAACI) Congress 2023
    Alladapt Announces Presentations at European Academy of (EAACI) Congress 2023

    16 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/16/2669796/0/en/Alladapt-Announces-Presentations-at-European-Academy-of-Allergy-and-Clinical-Immunology-EAACI-Congress-2023.html

    GLOBENEWSWIRE
    16 May 2023
    Share Share
    Alladapt Appoints Louise Peacock as Chief Regulatory Affairs and Quality Officer
    Alladapt Appoints Louise Peacock as Chief Regulatory Affairs and Quality Officer

    01 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/01/2658168/0/en/Alladapt-Appoints-Louise-Peacock-as-Chief-Regulatory-Affairs-and-Quality-Officer.html

    GLOBENEWSWIRE
    01 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search